Aldeyra Therapeutics, Inc. (ALDX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.9900 |
| Open | 3.9700 |
| Bid | 3.7600 x 1300 |
| Ask | 4.0000 x 2200 |
| Day's range | 3.7596 - 4.0700 |
| 52-week range | 2.3550 - 11.3300 |
| Volume | |
| Avg. volume | 947,347 |
| Market cap | 221.546M |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1060 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.88 |
- Simply Wall St.
Trade Alert: The CEO, President & Director Of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Todd Brady, Has Just Spent US$60k Buying 2.4% More Shares
Even if it's not a huge purchase, we think it was good to see that Todd Brady, the CEO, President & Director of Aldeyra...
- Simply Wall St.
Is Aldeyra Therapeutics (NASDAQ:ALDX) Using Debt In A Risky Way?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- Business Wire
Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
LEXINGTON, Mass., June 09, 2022--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Global Healthcare Conference.
© 2022 Yahoo. All rights reserved.
